Consumption Coagulopathy Follow-up

Updated: Aug 24, 2017
  • Author: Alexander Gozman, MD; Chief Editor: Robert J Arceci, MD, PhD  more...
  • Print
Follow-up

Further Outpatient Care

Follow-up care with subspecialists may be required depending on the patient's underlying disorder and clinical course.

Next:

Further Inpatient Care

Because most children with disseminated intravascular coagulation (DIC) are critically ill, serial monitoring of laboratory values is necessary. CBC count, prothrombin time (PT) and activated partial thromboplastin time (aPTT), D-dimers, and fibrinogen measurements should be frequently repeated.

Organ involvement and concurrent illness dictate the need for additional laboratory studies.

Previous
Next:

Inpatient & Outpatient Medications

The patient's underlying disorder and clinical course dictate the medications required at discharge.

Patients with chronic DIC may benefit from treatment with low molecular weight heparin (LMWH) on an outpatient basis. Recommended dosages are 1-1.5 mg/kg given subcutaneously every 12 hours.

Previous
Next:

Transfer

Transfer pediatric patients to tertiary care centers with a pediatric ICU and subspecialists.

Previous